Don’t want to clog the board but I had to point this out.
Leeps if you had bought Dexcom at the time of this article from Bloomberg, May of 2019 you would have paid about 125 per share, down, as the article points out, 20 points from March when the attack started. It never went much lower and today trades for 550 something.
So it looks like going against Spruce Point could pay big dividends. I can’t see this adding legitimacy.
Mike
9 Likes